» Articles » PMID: 29629372

Glomerular Endothelial Cell Stress and Cross-Talk With Podocytes in Early [corrected] Diabetic Kidney Disease

Overview
Specialty General Medicine
Date 2018 Apr 10
PMID 29629372
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic kidney disease (DKD) is one of the major causes of morbidity and mortality in diabetic patients and also the leading single cause of end-stage renal disease in the United States. A large proportion of diabetic patients develop DKD and others don't, even with comparable blood glucose levels, indicating a significant genetic component of disease susceptibility. The glomerulus is the primary site of diabetic injury in the kidney, glomerular hypertrophy and podocyte depletion are glomerular hallmarks of progressive DKD, and the degree of podocyte loss correlates with severity of the disease. We know that chronic hyperglycemia contributes to both microvascular and macrovascular complications, as well as podocyte injury. We are beginning to understand the role of glomerular endothelial injury, as well as the involvement of reactive oxygen species and mitochondrial stress, which play a direct role in DKD and in other diabetic complications. There is, however, a gap in our knowledge that links genetic susceptibility to early molecular mechanisms and proteinuria in DKD. Emerging research that explores glomerular cell's specific responses to diabetes and cell cross-talk will provide mechanistic clues that underlie DKD and provide novel avenues for therapeutic intervention.

Citing Articles

Cellular cross-talk drives mesenchymal transdifferentiation in diabetic kidney disease.

Chatterjee A, Tumarin J, Prabhakar S Front Med (Lausanne). 2025; 11():1499473.

PMID: 39839616 PMC: 11747801. DOI: 10.3389/fmed.2024.1499473.


PM Exposure Induces Glomerular Hyperfiltration in Mice in a Gender-Dependent Manner.

Wang H, Ma L, Guo Y, Ren L, Li G, Sang N Toxics. 2025; 12(12.

PMID: 39771093 PMC: 11679005. DOI: 10.3390/toxics12120878.


Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation of EMT and ROS-Sensitive Pathways in Diabetes.

Jandeleit-Dahm K, Kankanamalage H, Dai A, Meister J, Lopez-Trevino S, Cooper M Antioxidants (Basel). 2024; 13(4).

PMID: 38671844 PMC: 11047703. DOI: 10.3390/antiox13040396.


The crosstalk between glomerular endothelial cells and podocytes controls their responses to metabolic stimuli in diabetic nephropathy.

Albrecht M, Sticht C, Wagner T, Hettler S, de la Torre C, Qiu J Sci Rep. 2023; 13(1):17985.

PMID: 37863933 PMC: 10589299. DOI: 10.1038/s41598-023-45139-7.


Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease.

Jiang S, Su H Cell Commun Signal. 2023; 21(1):288.

PMID: 37845726 PMC: 10577991. DOI: 10.1186/s12964-023-01323-w.


References
1.
Birk A, Liu S, Soong Y, Mills W, Singh P, Warren J . The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013; 24(8):1250-61. PMC: 3736700. DOI: 10.1681/ASN.2012121216. View

2.
Woroniecki R, Schiffer M, Shaw A, Kaskel F, Bottinger E . Glomerular expression of transforming growth factor-beta (TGF-beta) isoforms in mice lacking CD2-associated protein. Pediatr Nephrol. 2006; 21(3):333-8. DOI: 10.1007/s00467-005-2102-7. View

3.
Mann J, Orsted D, Brown-Frandsen K, Marso S, Poulter N, Rasmussen S . Liraglutide and Renal Outcomes in Type 2 Diabetes. N Engl J Med. 2017; 377(9):839-848. DOI: 10.1056/NEJMoa1616011. View

4.
Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M . Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest. 2011; 121(6):2278-89. PMC: 3104773. DOI: 10.1172/JCI46322. View

5.
Babelova A, Avaniadi D, Jung O, Fork C, Beckmann J, Kosowski J . Role of Nox4 in murine models of kidney disease. Free Radic Biol Med. 2012; 53(4):842-53. DOI: 10.1016/j.freeradbiomed.2012.06.027. View